News

HIV Prevention: Dr Reddy’s Receives US FDA Tentative Approval for Generic Lenacapavir

The long-acting injectable lenacapavir is intended for HIV pre-exposure prophylaxis (PrEP), with initial supplies expected by the end of 2026.